MINI FUTURE SHORT - RECORDATI INDUSTRIA CHIMICA E FARMA | Market Closed - Borsa Italiana 04:04:59 2024-07-12 pm EDT | ||
| 4.29 EUR | -10.25% |
|
| Current month | -32.23% | ||
| 1 month | -26.42% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
Latest news about RECORDATI
| Date | Price | Change |
|---|---|---|
| 24-07-12 | 4.29 | -10.25% |
| 24-07-11 | 4.78 | -2.25% |
| 24-07-10 | 4.89 | -21.63% |
| 24-07-09 | 6.24 | +4.17% |
| 24-07-08 | 5.99 | +2.57% |
Real-time Borsa Italiana
Last update July 12, 2024 at 04:04 pm EDT
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | RECORDATI |
| Issuer | 
BNP Paribas
|
| P237P1 | |
| ISIN | NLBNPIT237P1 |
| Date issued | 2024-05-24 |
| Strike | 54.83 € |
| Maturity | 2035-12-20 (4178 Days) |
| Parity | 1 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 7.67 € |
|---|---|
| Lowest since issue | 4.27 € |
| Spread | 0.08 € |
| Spread % | 1.90% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
50.95
EUR
Average target price
52.64
EUR
Spread / Average Target
+3.32%
- Stock Market
- Certificates
- P237P1 Certificat
